2021 SABCS What Changes Monday Morning? Triple-Negative Breast Cancer Panel Discussion

(1:28:8)

2021 SABCS What Changes Monday Morning? HER2+ Breast Cancer Panel Discussion

(1:29:7)

2021 SABCS What Changes Monday Morning? Metastatic Breast Cancer Panel Discussion

(1:31:24)

Highlights from SABCS 2021

(1:57)

2021 SABCS What Changes Monday Morning? ER+ Breast Cancer Panel Discussion

(1:34:41)

What are you looking forward to at SABCS 2021?

(33)

Highlights from SABCS 2021

(54)

Scott Bessent on Musk and DOGE, Dollar, Fed Policy | Live Interview

(21:24)

Canada Day Performance - SATBB 2020

(29:17)

Beyond Celiac 2nd Annual Research Symposium

(1:31:34)

2021 SHS Awards Presentation

(1:13:49)

UCSF Bay Area Breast Cancer Forum: Updates from the San Antonio Breast Cancer Symposium 2021

(1:32:9)

HER2-Low Expression in Breast Cancer: Opportunities for Expanding Treatment Benefit to More Patients

(1:20:2)

2021 San Antonio Breast Cancer Symposium Update on MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

(59:15)

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

(17:14)

UCSF Bay Area Breast Cancer Forum: Breast Cancer at ASCO 2021: Hear from the experts!

(1:28:28)

Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)

(1:2:6)

2021 MDONS | Breast Cancer | Updates from San Antonio

(28:36)

Erica Mayer, MD, MPH PALLAS Trial SABCS 2021

(4:40)

Recent breast cancer updates from SABCS 2021

(1:7)

Highlights at SABCS 2021 for basic science and early-phase clinical trials

(1:32)

SABCS 2021: Key Findings in Breast Cancer Research

(49:46)

What to look out for at SABCS 2022

(44)

Highlights from SABCS 2021: T-DXd, KEYNOTE-355, PADA-1 \u0026 EMERALD

(3:7)

Adjuvant/neoadjuvant therapy trials for breast cancer at SABCS 2021

(2:31)

Report Back from SABCS 2021: What’s the Latest in Metastatic Breast Cancer Research?

(1:1:53)

Highlights in HER2-low breast cancer at SABCS 2022

(32)

Key clinical trials in breast cancer presented at SABCS 2021

(2:56)

Exciting trials at SABCS 2021 for pre- vs. post-menopausal hormone receptor-positive breast cancer

(2:11)